Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Related Post

International Congress for Ataxia Research 2024

  • Posted on 12 November, 2024
    Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
    Read more

    Redenlab at the 2nd Annual Lysosomal Disease Summit 2024

    • Posted on 14 October, 2024
      Redenlab is pleased to announce that Dr. Adam Vogel, an expert in speech and language function, will be presenting at...
      Read more

      Redenlab at the Digital Health and AI Innovation Summit 2024

      • Posted on 4 September, 2024
        Dr. Adam Vogel, CSO of Redenlab, will be speaking alongside Dr. Tairmae Kangarloo, Associate Director of Digital Strategy at Takeda,...
        Read more